Moyamoya disease is a rare cerebrovascular disease characterized by idiopathic bilateral stenosis or occlusion of bilateral internal carotid arteries and the development of characteristic leptomeningeal collateral vessels at the base of the brain. Typical presentations include transient ischemic attacks or stroke, and hemorrhage. Presentation with movement disorders is extremely rare, especially in the pediatric population. The authors describe the cases of 4 children with moyamoya disease who presented with movement disorders.
M oyaMoya disease is a rare chronic cerebrovascular disease characterized by idiopathic gradual stenosis or occlusion of bilateral supraclinoid ICAs, resulting in the characteristic development and appearance of an abnormal vascular network resembling a "puff of smoke." 26 First described by Takeuchi and Shimizu, 28 moyamoya disease was long thought to be rare outside of Asia. However, there are increasing reports from Europe and North America regarding the clinical presentation and management of this rare disease. 10, 29 Typical presentations include TIAs or ischemic strokes in children and hemorrhage in adults. Atypical presentations include headaches, seizures, cognitive impairment, and dementia. 4, 12 Movement disorders as presenting features in patients with moyamoya disease are extremely rare. Symptoms of such disorders probably arise from ischemia or changes in the excitatory and inhibitory circuits interconnecting the basal ganglia and cerebral cortex. In a majority of the prior case reports, ischemia involved the frontal subcortical matter, and basal ganglia ischemia causing movement disorders was uncommonly reported. Although this presentation has been described in case reportsdiscussed. In the present report, we describe a series of 4 children with moyamoya disease presenting with movement disorders. We review their clinical presentations, imaging characteristics with an emphasis on MR images and cerebral flow patterns, and the effects of revascularization surgery on their symptomatology.
Methods
A retrospective review of a moyamoya disease database was conducted to look for the clinical presentation of the patients. All patients were surgically treated by the senior author (G.K.S.) between January 1991 and April 2010 at the Department of Neurosurgery, Stanford University Medical Center. Among the 446 patients (118 pediatric) included in the database, 4 pediatric patients had presented with movement disorders. They constituted 0.89% of all patients and 3.4% of all pediatric patients with moyamoya disease in our experience.
All 4 patients were evaluated using MR imaging, cerebral perfusion studies such as an acetazolamide-challenge SPECT, and 6-vessel cerebral angiography, according to the published guidelines. 5 Three of the 4 patients had bilateral moyamoya disease and hence were treated with direct bilateral revascularization using STA-MCA bypass. One patient had unilateral moyamoya disease; therefore, revascularization was performed only on the symptomatic side. The STA was also laid on the cerebral cortex as described in the EDAS procedures. The evolution of the symptomatology, specifically the presenting symptoms, was carefully recorded for each case. Cerebral flow studies with 99m Tc-HMPAO SPECT were performed both preoperatively and 6 months to 3 years postoperatively. All patients also underwent MR imaging to detect any new ischemic lesions and cerebral angiography to assess graft patency and collateral vessels postoperatively. All the patients underwent follow-up, which ranged from 3 to 11 years (mean ± SD, 5.25 ± 3.8 years).
Case Reports
Of 446 patients (118 pediatric) with moyamoya disease treated over a 19-year period, 4 patients presented with movement disorders as their primary symptom. A summary of patient demographics and clinical presentations is listed in Table 1 .
History and Examination. The patient in Case 1 was an 8-year-old boy who presented with involuntary choreiform movements involving the right upper limb. Movement was intermittent, not present during sleep, and exacerbated by any voluntary movements. The boy also had TIAs with numbness involving the right side of the body along with transient aphasia that came after the onset of the chorea. The patient in Case 2 was an 8-year-old girl who also presented with involuntary movements involving the right side of the body (the upper limb more than the lower limb), as well as transient slurring of her speech. The patient in Case 3 was a 17-year-old girl who presented with involuntary movements involving both sides, although the right side more than the left, over the past year. She had also presented with a left hemispheric infarct 5 months previously, with partial recovery. Her significant medical history included Type 1 GSD. The patient in Case 4 was an 18-year-old man who presented with a 9-month history of flailing movements involving the right arm, which was suggestive of hemiballismus. This disorder was intermittent, without any specific exacerbating or relieving factors. He did not have any TIAs or previous strokes. Two of the patients' symptoms were partially controlled with clonazepam and trihexyphenidyl. Neurological examination revealed mild weakness involving the right side in the patient in Case 3 and mild clumsiness involving the right hand in the patient in Case 1.
Imaging. Magnetic resonance images of the brain were obtained in all the patients. Imaging in 3 demonstrated small ischemic watershed infarcts involving bilateral frontal subcortical white matter. Images from Case 3 are featured in Fig. 1 . None of the patients had a cortical infarct, although 1 patient had a ganglionic infarct in addition to the watershed infarcts. Magnetic resonance imaging results were nondiagnostic in 1 patient. Of note, none of the patients (in the entire moyamoya database) who had basal ganglia hematomas presented with move- Tc-HMPAO SPECT in all patients at baseline and after the Diamox challenge ( Fig. 2 and Table 2 ).
Operation. All the patients underwent STA-MCA bypass for direct revascularization. The STA diameter ranged from 0.9 to 1.2 mm, and the M 4 vessel diameter ranged from 1.0 to 1.4 mm. The STA was also laid on the cerebral cortex as an EDAS for indirect revascularization. Three patients (Cases 1-3) underwent bilateral procedures. The symptomatic side (left hemisphere in all cases) was treated first, followed by the right side 1 week later. The patient who presented with hemiballismus had unilateral moyamoya disease (Case 4) and thus underwent left-sided surgery only.
Postoperative Course. In 3 patients (Cases 1-3), the movement disorder resolved over 2 days to 1 week. Resolution of the hemiballismus was the most dramatic, which disappeared 2 days after surgery (Case 4). Medications to control movement disorders, such as clonazepam or trihexyphenidyl, were stopped on discharge. In 1 patient with chorea (Case 3), the involuntary movements decreased in frequency, although their complete disap- pearance took 6 months; thereafter, the patient did not have any relapse over a follow-up period of 11 years. She remained on clonazepam for 6 months, after which it was stopped. Postoperative brain MR imaging did not reveal fresh ischemic lesions in any patient. The follow-up ranged from 3 to 11 years (mean 5.25 ± 3.8 years). None of the patients experienced any relapse of the movement disorder. Three patients fared well clinically and remained free of TIA and stroke. Cerebral flow studies revealed normal perfusion in all 3 of these patients. Images obtained in the patient in Case 3 are featured in Figs. 1-5 . This girl with Type 1 GSD had occasional TIAs for 3 years; thereafter, she was free of symptoms for 8 years. Flow studies in this patient demonstrated bilateral residual perfusion deficits. Follow-up angiography in all of the patients showed widely patent grafts with good revascularization of the MCA territory. Preoperative and postoperative images obtained in the 
Discussion
Moyamoya disease is an uncommon cerebrovascular disease characterized by idiopathic bilateral stenosis or occlusion of the supraclinoid ICA with involvement of the proximal anterior cerebral artery and MCA, as well as the formation of collateral vessels resembling a puff of smoke. 26 The most common presentation in the pediatric population is with TIAs or stroke, 7 although presentation with movement disorders has been reported in both the adult and pediatric populations.
Involuntary movements are generated due to a disruption in the fine balance between excitatory and inhibitory signals connecting basal ganglia and cerebral cortex via direct and indirect pathways. 3, 5 Ischemic dysfunction of basal ganglia, the thalamus, cerebral cortex, and brainstem have been implicated as causes of simple or complex movement disorders. Previous reports (Table 3 ) on 13 pediatric patients with moyamoya disease have suggested that ischemia of both the frontal subcortical matter and the basal ganglia are important in the generation of involuntary movements. 2, 8, 11, 13, 14, [16] [17] [18] [19] [20] [21] 24, 25, [30] [31] [32] In addition, Scott and colleagues 22, 23 mentioned in their reviews of moyamoya disease 10 pediatric patients presenting with involuntary movements. Eight of these patients had a resolution of symptoms 1 year after revascularization surgery. Baik and Lee 1 also reported on 4 patients and reviewed the literature on moyamoya disease presenting with movement disorders. Unfortunately, the results in these 4 patients were not described separately. Im et al.
14 documented 6 patients with an ischemic cause of their movement disorders, which included 5 cases of moyamoya disease and 1 case of radiation-induced MCA stenosis. These authors suggested that the subcortical circuits were more important, and they did not identify any basal ganglionic infarction or ischemia in patients with involuntary movements due to cerebral ischemia. Note, however, that 2 of their patients presented with limb-shaking, which can be a sign of cerebral ischemia. 17 On the other hand, Hong et al. 13 described a patient with moyamoya disease presenting with hemichorea and reversible striatal hypoperfusion on SPECT. In the present series, we observed bilateral subcortical ischemia in most cases. In 1 patient presenting with previous stroke, however, there was evidence of a small ganglionic infarct as well. We hypothesize that any ischemia or lesion that interrupts the cortico-striatal-pallidal-thalamic-cortical pathway and disrupts the fine circuitry causes involuntary movements. However, it remains unclear why movement disorders are such an uncommon presenting feature, especially given that ischemia in this circuit occurs in many cases of moyamoya disease. Quantitative cerebral blood flow measurements with Xe-CT and PET might be useful in establishing the relative ischemia among various cortical, subcortical, and deep structures, as well as their relative importance in the generation of symptomatology.
The surgical treatment of moyamoya disease can be categorized into direct and indirect revascularizations. We have previously published our overall results following 450 revascularization procedures 9 and the outcomes of such interventions in the pediatric population. 6 The morbidity and mortality rates in the procedures were 3.5% and 0.7%, respectively, and 91.8% of the patients presenting with TIAs were free of symptoms at the 1-year follow-up. We prefer direct revascularization of the hemisphere whenever possible, because it immediately increases blood flow to the ischemic territory and because there are reports that STA-MCA bypass combined with encephaloduroarteriomyosynangiosis has better results compared with an indirect procedure alone. 15 In the present case series, we did not encounter any significant morbidity. Most of the patients had a dramatic resolution of symptoms, leading us to believe that their involuntary movements were ischemic in origin. One patient (Case 3) with Type 1 GSD had after revascularization occasional involuntary movements for 6 months and TIAs for 3 years despite angiographically proven widely patent grafts. It is possible that the metabolic derangements due to GSD contributed to the persistence of symptoms, although the symptoms did eventually resolve.
Conclusions
Movement disorders can be a rare presentation of moyamoya disease and are likely to be caused by ischemic dysfunction and imbalance in the cortical-subcortical-ganglionic-thalamic-cortical circuitry. Direct revascularization leads to an excellent outcome and lasting relief from symptoms. Quantitative blood flow studies are likely to provide further insights into the generation of the symptomatology of this disease. 
